Australija - anglų - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - nonacog beta pegol, quantity: 500 iu/ml - injection, solvent for - excipient ingredients: sodium hydroxide; hydrochloric acid; histidine; water for injections - treatment and prophylaxis of bleeding in patients 12 years and above with haemophilia b (congenital factor ix deficiency).

Australija - anglų - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - nonacog beta pegol, quantity: 250 iu/ml - injection, solvent for - excipient ingredients: hydrochloric acid; sodium hydroxide; histidine; water for injections - treatment and prophylaxis of bleeding in patients 12 years and above with haemophilia b (congenital factor ix deficiency).

Australija - anglų - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - nonacog beta pegol, quantity: 125 iu/ml - injection, solvent for - excipient ingredients: histidine; water for injections; sodium hydroxide; hydrochloric acid - treatment and prophylaxis of bleeding in patients 12 years and above with haemophilia b (congenital factor ix deficiency).

Europos Sąjunga - graikų - EMA (European Medicines Agency)

novo nordisk a/s - nonacog beta πεγόλη - Αιμορροφιλία Β - Αντιαιμορραγικά - Θεραπεία και προφύλαξη της αιμορραγίας σε ασθενείς με αιμορροφιλία Β (συγγενής ανεπάρκεια παράγοντα ix). , refixia can be used for all age groups.

Europos Sąjunga - islandų - EMA (European Medicines Agency)

novo nordisk a/s - nonacog beta pegol - hemophilia b - antihemorrhagics - meðferð og fyrirbyggja blæðingar í sjúklinga með dreyrasýki b (meðfædda þáttur laga skort). , refixia can be used for all age groups.

Europos Sąjunga - slovakų - EMA (European Medicines Agency)

novo nordisk a/s - nonacog beta pegol - hemofília b - antihemoragiká - liečba a profylaxia krvácania u pacientov s hemofíliou b (vrodený nedostatok faktora ix). , refixia can be used for all age groups.

Europos Sąjunga - slovėnų - EMA (European Medicines Agency)

novo nordisk a/s - nonacog beta pegol - hemofilija b - antihemoragije - zdravljenje in profilaksa krvavitve pri bolnikih s hemofilijo b (prirojene pomanjkljivosti faktorja ix). , refixia can be used for all age groups.

Europos Sąjunga - švedų - EMA (European Medicines Agency)

novo nordisk a/s - nonacog beta pegol - hemofili b - hemostatika - behandling och profylax av blödning hos patienter med hemofili b (medfödd faktor ix-brist). , refixia can be used for all age groups.

Europos Sąjunga - italų - EMA (European Medicines Agency)

novo nordisk a/s - nonacog beta pegol - emofilia b - antiemorragici - trattamento e profilassi delle emorragie in pazienti con emofilia b (congenita carenza di fattore ix). , refixia can be used for all age groups.

Europos Sąjunga - čekų - EMA (European Medicines Agency)

novo nordisk a/s - nonacogum beta pegol - hemofilie b - antihemoragika - léčba a profylaxe krvácení u pacientů s hemofilií b (vrozený nedostatek faktoru ix). , refixia can be used for all age groups.